News & Events – Sumitovant

Select Company

November 04, 2021Spirovant Presents Preclinical Data Showing SP-101 Restores CF Transmembrane Conductance Regulator Function at the 2021 North American Cystic Fibrosis Conference
January 26, 2021Spirovant Continues Rapid Growth with New Headquarters and Expanded Leadership
October 13, 2020Spirovant CEO Joan Lau Selected EY Entrepreneur of The Year® in Greater Philadelphia
October 07, 2020Spirovant CEO Joan Lau Selected as a Woman of Distinction by Philadelphia Business Journal
September 24, 2020FDA Grants Spirovant Sciences Orphan Drug and Rare Pediatric Disease Designations for SPIRO-2101 for Treatment of Cystic Fibrosis
September 03, 2020Spirovant CEO Joan Lau Named Finalist for EY Entrepreneur of The Year® in Greater Philadelphia
May 13, 2020Spirovant Sciences Appoints Roland Kolbeck, PhD, as Chief Scientific Officer